We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Johnson and Johnson | NYSE:JNJ | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 0.68 | 0.45% | 150.60 | 149.89 | 147.82 | 149.89 | 6,531,681 | 00:25:31 |
From May 2019 to May 2024
"J&J Plans to Add Drug Discovery and Early Research to Actelion Unit," at 1:05 p.m. EDT, incorrectly stated that J&J's initial stake would be 16% in the final paragraph. A J&J subsidiary initially will hold a 9.9% stake in the new company, with an option to increase this to 32% in the future. (June 14)
(END) Dow Jones Newswires
June 14, 2017 15:36 ET (19:36 GMT)
Copyright (c) 2017 Dow Jones & Company, Inc.
1 Year Johnson and Johnson Chart |
1 Month Johnson and Johnson Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
